Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples